Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Internal Medicine, Hallym University Kangdong Sacred Heart Hospital, Seoul, Korea.
Lung Research Institute of Hallym University College of Medicine, Chuncheon, South Korea.
Ther Adv Respir Dis. 2020 Jan-Dec;14:1753466620961688. doi: 10.1177/1753466620961688.
Patients discharged after treatment for acute exacerbation of chronic obstructive pulmonary disease (COPD) are at high risk for readmission. We aimed to identify the prevalence and risk factors for readmission.
We included 16,105 patients who had claimed their medical expenses from 1 May 2014 to 1 May 2016 after discharge from any medical facility in Korea, following treatment for acute exacerbation of COPD. We analysed the potential risk factors for readmission within 30 days of discharge.
Readmission rate was 26.4% (3989 patients among 15,101 patients) and over 50% of readmissions occurred within 10 days of discharge. Approximately 57% of readmissions occurred due to respiratory causes. Major causes of readmission were COPD (27%), pneumonia (14.2%), and lung cancer (7.1%), in that order. Patients who were readmitted were male, had more comorbidities and were less frequently admitted to tertiary hospitals than those who were not readmitted. Risk factors for readmission within 30 days of discharge were male sex, medical aid coverage, longer hospital stay, longer duration of systemic steroid use during hospital stay, high comorbid condition index, and discharge to skilled nursing facility.
Readmission occurred in approximately one-quarter of patients, and was associated with patient-related and clinical factors. Using these results, we can identify high-risk patients for readmission and precautions are needed to be taken before deciding on a discharge plan. Further research is needed to develop accurate tools for predicting the risk of readmission before discharge, and development and evaluation of an effective care programme for COPD patients are necessary..
慢性阻塞性肺疾病(COPD)急性加重期治疗后出院的患者再入院风险较高。本研究旨在确定再入院的患病率和危险因素。
我们纳入了自 2014 年 5 月 1 日至 2016 年 5 月 1 日期间,在韩国的任何医疗机构治疗 COPD 急性加重后出院的 16105 例患者,分析了出院后 30 天内再入院的潜在危险因素。
再入院率为 26.4%(15101 例患者中有 3989 例),超过 50%的再入院发生在出院后 10 天内。再入院的主要原因为呼吸系统疾病(57%),其次为 COPD(27%)、肺炎(14.2%)和肺癌(7.1%)。与未再入院患者相比,再入院患者中男性比例较高、合并症较多、较少入住三级医院。30 天内再入院的危险因素包括男性、医疗补助覆盖、住院时间延长、住院期间全身皮质类固醇使用时间延长、合并症指数较高和出院至康复护理机构。
大约四分之一的患者发生再入院,再入院与患者相关因素和临床因素相关。利用这些结果,可以确定再入院的高危患者,并在制定出院计划前采取预防措施。需要进一步研究,以开发出准确的工具,在出院前预测再入院的风险,并为 COPD 患者制定和评估有效的护理方案。